CuraGenix Life Sciences

Menu
Facebook Twitter Youtube

About
CuraGenix

Vision

Creating a healthier tomorrow

Mission

Dedicated to delivering accessible, high-quality medicines, our mission is to improve global health outcomes by providing cost-effective innovative medications that meet the diverse, unmet needs of patients and healthcare systems. We achieve this through innovation, ethical practices, and a relentless commitment to quality and affordability.

Please get in touch with us, we are seeking new partners

Play Video

Our
Story

CuraGenix life sciences is part of the CST group spending over 20 years in wholesale, retail, consumer products, specials supply, medical devices, we are thrilled to announce our new business segment into the Pharmaceutical and biological business. We have track record of timely development and registration, along with strategic and effective marketing across the globe.

Commercial capability:

A strong team with deep knowledge of the UK/global healthcare systems for hospitals, wholesale as well as retail pharmacy.

Regulatory capability:

Multinational experience of regulatory submissions to the relevant agencies

CST Pharma

Meet Our Team

Jonathan Dally

Business intelligence and clinical affairs
See More

Carl Falzon

Commercial Director
See More

Jason Yates

Managing Director
See More

QA, QC and Risk Management:

Our Quality and Risk management head has extensive global experience including countries like US, China, HK, Japan, UK, Costa Rica, Central American Countries, Africa, Switzerland.  She has successfully faced auditors of USFDA, WHO Geneva, Ukraine, Uganda, RNTCP, and MSF France, and Japan (PMDA), MHRA, ANVISA, Argentina and Korea.  She has led multiple strategic transformation initiatives for Quality Management Systems, Quality control and management practices to drive Quality Culture. She has won several awards for her extraordinary leadership potentials in delivering innovative solutions for compliance, developing people capabilities and achieving all time readiness.

Technical, Development & Regulatory

The Research and Technical Head has amassed extensive international experience, having worked in multiple countries including the United Kingdom, Austria, Germany, Singapore, Malaysia, China, Hong Kong, and India. Throughout his career, he has collaborated with several prestigious global Multinational Corporations (MNCs). His expertise particularly shines in the realm of novel drug delivery systems, where he has demonstrated a profound understanding and innovative approach. Furthermore, his proficiency extends to navigating the intricate landscape of regulatory submissions to various relevant agencies. This multifaceted skill set makes him a valuable asset to our organisation or project in the pharmaceutical and healthcare sectors, where innovation, international collaboration, and regulatory compliance are of paramount importance.

Contact
Locations

UK

5-7 Tintagel way ,
Aldridge , Walsall, WS9 8ER
+44 1922 472245

India

+91 78925 28594

Spain

Sede Central Y Almecen,
GINESTAR,7, Domey Nord, 17007, Girona.
+34 972 396 500

Jason Yates

a seasoned leader and Managing Director of the CST Group of companies. With over two decades of experience in the healthcare and pharmaceutical industry, Jason has a proven track record of driving strategic initiatives, optimizing operations, and fostering strong relationships with suppliers and stakeholders. Jason is committed to innovation, growth, and ensuring the delivery of vital pharmaceuticals to healthcare providers across the world

Carl Falzon

is a dynamic and results-driven Commercial Director with a robust background in the pharmaceutical industry. With a career spanning over 20 years, Carl has displayed expertise in developing and executing commercial strategies that drive business growth and market expansion. His leadership has been instrumental in forging successful partnerships, negotiating key contracts, and implementing innovative sales and marketing initiatives to enhance market presence. Carl's sharp business acumen, coupled with a deep understanding of market dynamics, has consistently contributed to the success and profitability of the company's commercial operations, positioning the firm as a prominent player in the pharmaceutical sector.

Jonathan Dally

Jonathan is Our head of Business Development / Business Intelligence and Clinical Affairs has over 25 years of UK Pharma experience, covering various sectors including Clinical Trials, NHS tenders, Trade mark registration, Business Intelligence/ Business Development  and Clinical Affairs. He has a proven history of successfully managing several national / international clinical trials and more recently he has been hugely successful in attaining numerous NHS tender awards since 2018, including several National NHS Framework Agreement tender awards.  Furthermore, he is an author of academic and clinical trial-based publications,  As a leader and driver of business project programmes through effective project management, in accordance with the Company's processes, he has successfully collaborated with EU partners leading to the uptake of newly approved generic lines by the NHS (in both retail and hospital markets) and the regulatory submission of a new product line to the MHRA. In his current role, he provides science-based and clinical-based advice to the Senior Management Team/Board regarding in—licensing opportunities and acquisitions, as well as for collaborations with potential commercial partners wishing to sell licenced medicines, food supplements and medical devices in the UK.  He also performs due diligence reviews of potential product acquisitions / partnership opportunities and he works directly with contractors in order to ensure on-time and cost-effective delivery of high-quality output. He holds a BSc (Hons) degree in Pharmacology from Bath University and a Doctor of Philosophy (DPhil) degree from the University of Oxford.